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Introduction
DNA damage response mechanisms function to maintain ge-
nomic stability in normal cells. Because genomic instability is a 
characteristic of cancer cells, it is evident that at least some of 
these damage response pathways become impaired during pro-
gression to carcinogenesis. Additionally, patients with defective 
damage response pathways frequently show cancer predisposi-
tion, of which ataxia telangiectasia (A-T) is a well-known ex-
ample. Signifi  cant insight has been gained into the roles of 
individual damage response pathways. Understanding the effi  -
ciency as well as the interplay between them is an important 
next step (Difi  lippantonio et al., 2000; Gao et al., 2000).
DNA double-strand break (DSB) repair and cell cycle 
checkpoint arrest represent two pathways to maintain genomic 
stability (van Gent et al., 2001; Wahl and Carr, 2001; Lieber et al., 
2003; Kruhlak et al., 2006; Bekker-Jensen et al., 2006; Mari 
et al., 2006). A-T mutated (ATM) plays a critical role in regulat-
ing cell cycle checkpoint arrest in response to DSBs (Shiloh, 
2003; Ward and Chen, 2004; Lou et al., 2006) and regulates a 
component of DSB repair (Kühne et al., 2004; Riballo et al., 
2004). The prevailing evidence suggests that in G0/G1, ATM is 
required for Artemis, a nuclease, to process a subset ( 15%) of 
radiation-induced DSBs before rejoining. A-T, a disorder caused 
by mutations in ATM, is associated with pronounced chromo-
somal instability, cancer susceptibility, and clinical radiosensi-
tivity. This has generally been attributed to ATM’s role in cell 
cycle checkpoint regulation. However, older cytogenetic data 
(Cornforth and Bedford, 1985; Jeggo et al., 1998) and the recent 
repair defect described in A-T cells (Riballo et al., 2004) raises 
the issue of how ATM’s repair and checkpoint functions inter-
play to maintain chromosome stability. Here, we exploit A-T 
as a model to defi  ne the effi  ciency and dissect the interplay be-
tween DNA repair and cell cycle checkpoint pathways, focus-
ing our attention on two ATM-dependent functions, DSB repair 
in G2 and G2/M checkpoint arrest.
Results and discussion
ATM- and Artemis-dependent DSB repair 
operates in G1 and G2
To investigate the contribution of ATM and Artemis to DSB 
  repair in cell cycle phases other than G0, we analyzed asynchro-
nously growing cell cultures to avoid the potential introduction 
of DSBs during synchronization. In one approach, we used pan-
nuclear centromere protein F (CENP-F) staining to identify G2 
cells (Liao et al., 1995; Kao et al., 2001; Fig. S1 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200612047/DC1) and 
added aphidicolin to prevent S phase cells from progressing into 
G2 during analysis. Mitotic cells exhibiting distinct centromeric 
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NA double-strand break (DSB) repair and check-
point control represent distinct mechanisms to re-
duce chromosomal instability. Ataxia telangiectasia 
(A-T) cells have checkpoint arrest and DSB repair defects. 
We examine the efﬁ   ciency and interplay of ATM’s G2 
checkpoint and repair functions. Artemis cells manifest a 
repair defect identical and epistatic to A-T but show proﬁ  -
cient checkpoint responses. Only a few G2 cells enter 
  mitosis within 4 h after irradiation with 1 Gy but manifest 
multiple chromosome breaks. Most checkpoint-proﬁ  cient 
cells arrest at the G2/M checkpoint, with the length of 
  arrest being dependent on the repair capacity. Strikingly, 
cells released from checkpoint arrest display one to two 
chromosome breaks. This represents a major contribution 
to chromosome breakage. The presence of chromosome 
breaks in cells released from checkpoint arrest suggests 
that release occurs before the completion of DSB repair. 
Strikingly, we show that checkpoint release occurs at a 
point when approximately three to four premature chromo-
some condensation breaks and  20 γH2AX foci remain.
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CENP-F staining and condensed chromatin were excluded from 
analysis. Under these conditions, S phase cells do not progress 
into G2 (Fig. S1 B) and a considerable proportion of cells irra-
diated with 1.5 Gy x-rays remain positive for pan-nuclear 
CENP-F staining for 6–8 h (i.e., they remain in G2), providing 
suffi  cient time to detect the ATM/Artemis repair defect, which 
is measurable at >4 h after irradiation in G0 cells.
Enumeration of γH2AX foci in aphidicolin-treated CENP-F–
positive primary human fi  broblasts after 1.5 Gy x-irradiation 
demonstrated that ATM- and Artemis-dependent DSB repair 
operates in G2 (Fig. 1 A). Aphidicolin treatment did not affect 
the repair capacity of G2 cells (Fig. S1 C) but caused pro-
nounced H2AX phosphorylation in cells that were CENP-F 
negative but positive for the S/G2 marker, cyclin A, most likely 
because of the activation of ATR after replication arrest (Fig. S1 A). 
Enumeration of γH2AX foci in CENP-F–negative cells that 
were also negative for the pronounced, aphidicolin-induced 
γH2AX phosphorylation allowed the analysis of repair in G1 
phase cells (Fig. 1 A). For all cell lines, we observed similar 
  kinetics and magnitude of repair in G1 and G2, which was also 
similar to that previously observed in G0 cells (Riballo et al., 
2004). Foci numbers correlated with DNA content being twice 
as high in G2 compared with G1 (Fig. 1 A). In analogy to our 
previous study (Riballo et al., 2004), we confi  rmed that ATM 
and Artemis operate in the same repair pathway by analyzing 
the repair defect in Artemis cells treated with the specifi  c ATM 
small molecule inhibitor KU55933 (Hickson et al., 2004). The 
dual defi  ciency in Artemis and ATM did not cause an increased 
repair defect relative to the defect in Artemis cells (Fig. 1 B). 
Thus, ATM and Artemis are epistatic in G1 and G2 and function 
to repair a subfraction of DSBs similar to that observed in con-
fl  uent cells. Because our results were obtained with nonisogenic 
human cell lines, we also investigated γH2AX foci formation in 
matching wild-type (WT), A-T, and Artemis mouse embryonic 
fi  broblasts (MEFs) using procedures similar to those used with 
human cells and observed identical repair kinetics (Fig. S1 D).
To substantiate that γH2AX foci analysis monitors DSB 
repair, we developed and applied a pulsed-fi  eld gel electropho-
resis (PFGE) technique to monitor DSB repair specifi  cally in 
G2 phase cells (Fig. 1 C). Exponentially growing primary hu-
man fi  broblasts were pulse-labeled with [methyl-
3H]thymidine 
for 1 h and irradiated with 80 Gy 4 h after labeling (when in G2; 
Fig. S1 E). After 48 and 72 h of repair, cells were harvested and 
the fraction of radioactivity released (FAR) from the gel plug 
Figure 1.  A-T and Artemis primary human ﬁ  broblasts exhibit a 
DSB repair defect in G1 and G2. (A) γH2AX foci analysis in G1 
and G2 phase cells after 1.5 Gy x-irradiation. Background foci 
numbers were  2 in G2 and 0.2 in G1. (B) γH2AX foci analysis 
in G1 and G2 phase cells after 1.5 Gy x-irradiation in the ab-
sence or presence of the ATM small molecule inhibitor KU55933 
(ATMi). (C) FAR assay of [methyl-
3H]thymidine-labeled exponen-
tially growing cells irradiated in G2. (left) Ethidium bromide–
stained PFGE gel from primary human ﬁ  broblasts irradiated with 
10 Gy (for assessing DSB induction) or 80 Gy (for 48- and 72-h 
repair points) x-rays. The image has been grouped from different 
parts of the same gel for clarity. Note that the ethidium bromide 
signal represents DNA from all cells (G1, S, and G2) and is not 
used for evaluation. (right) FAR values calculated from the scintil-
lation counts of gel slices derived from PFGE gels. Error bars indi-
cate SEM.CHROMOSOME BREAKAGE AFTER G2 CHECKPOINT RELEASE • DECKBAR ET AL. 751
into the gel was quantifi  ed by liquid scintillation counting. The 
FAR values after repair incubation provide an estimate of the 
level of unrepaired DSBs and can be compared with FAR values 
obtained from samples analyzed immediately after irradiation 
without repair. FACS analysis of parallel samples labeled with 
BrdU instead of [methyl-
3H]thymidine showed that labeled 
cells have progressed to late S/G2 at the time of irradiation (4 h 
after labeling) and remained in G2 for at least 72 h after irradia-
tion with 80 Gy (Fig. S1 E). We obtained a similar level of un-
repaired DSBs in A-T and Artemis cells, which was similar to 
(or slightly higher than) the level of DSBs induced in cells irra-
diated with 10 Gy and not incubated for repair (i.e.,  1/8 of the 
DSBs induced by 80 Gy remain unrepaired; Fig. 1 C). Thus, the 
magnitude of the G2 repair defect measured by PFGE is similar 
to the  15% repair defect observed by γH2AX foci analysis 
of G2 or G1 cells (Fig. 1 A) and confl  uent cells (Riballo et al., 
2004). The identical repair defect of A-T and Artemis cells in 
G2 and G1 is perhaps surprising, given that ATM has been re-
ported to be required for homologous recombination. One pos-
sible explanation is that Artemis has a role in DSB repair 
processes other than nonhomologous end joining. Alternatively, 
our fi  ndings could indicate that the majority of ionizing radia-
tion (IR)–induced DSBs are repaired by nonhomologous end 
joining in G1 and G2. In support of this, we have observed that 
DNA ligase IV– and Ku80-defi  cient MEFs have a similar, ma-
jor DSB repair defect in G1 and G2 (unpublished data).
Artemis cells show normal checkpoint 
induction and prolonged G2/M arrest
Previously, we presented evidence that Artemis cells show nor-
mal G2/M checkpoint activation assessed by counting mitotic 
cells up to 9 h after IR (Riballo et al., 2004). Subsequently, 
Zhang et al. (2004), using phosphoH3 FACS analysis, con-
cluded that cells treated with Artemis siRNA show premature 
release from the G2/M checkpoint, implicating Artemis in 
IR-induced checkpoint responses. To examine the maintenance 
as well as the activation of G2/M arrest, we counted mitotic cells 
up to 24 h after IR in cells treated with nocodazole to accumu-
late cells in mitosis. We confi  rm that Artemis cells, in contrast 
to A-T cells, show normal G2/M checkpoint induction and, im-
portantly, remain arrested for the same length and possibly 
greater than WT cells (Fig. S2 A, available at http://www.jcb.org/
cgi/content/full/jcb.200612047/DC1).
We next analyzed the G2/M checkpoint by phosphoH3 
FACS analysis and observed checkpoint activation in Artemis 
but not A-T cells (Fig. 2 A). WT cells were released from check-
point arrest 4–6 h after 1.3 Gy and 12 h after 6 Gy x-irradiation. 
Artemis cells were released slightly later after 1.3 Gy and failed 
to be released for at least 16 h after 6 Gy (Fig. 2 A and Fig. S2 B). 
Normal checkpoint induction and a prolonged arrest at the 
G2/M border was also observed in irradiated Artemis MEFs 
compared with WT MEFs (Fig. 2 B). We also evaluated the 
time course for the progression of G2 cells through mitosis into 
G1 by analyzing BrdU-labeled cells. Exponentially growing 
 fi broblasts were pulse-labeled with BrdU for 1 h and irradiated 
with 1 Gy 4 h after labeling (when in G2). G2/M checkpoint 
arrest results in the retention of BrdU-labeled cells in G2. 
Quantifi  cation of the BrdU-labeled G2 cells for up to 12 h af-
ter irradiation confi  rmed that Artemis cells exhibit a prolonged 
G2/M arrest (Fig. 2 C). The prolonged arrest of Artemis cells in 
Fig. 2 was less evident in the experiments involving mitotic 
counting (Fig. S2 A), which may refl  ect the use of nocodazole 
in the latter approach, which delays reentry from G2/M arrest. 
Our observation of a prolonged arrest in Artemis cells is consis-
tent with a role of Artemis in DSB repair in G1 and G2. One 
  explanation for the difference between our results and those of 
Zhang et al. (2004) is that their study used human tumor cells 
for siRNA knock down of Artemis. Such cells frequently  behave 
aberrantly because of abnormal levels of Chk1/Chk2 or cell 
  cycle checkpoint regulation.
ATM’s G2 checkpoint and repair functions 
both contribute to the avoidance of 
chromosome breakage
Having established that Artemis affects ATM’s role in G2 DSB 
repair but not its function in G2 checkpoint control, we wished 
to evaluate the contribution of these two ATM functions to the 
prevention of chromosome aberrations in primary human WT, 
A-T, and Artemis fi  broblasts (Fig. 3). We focused on chromo-
some breaks arising from G2-irradiated cells by adding aphidi-
colin to prevent S phase cells from progressing into G2 during 
analysis. Growing cell populations were irradiated with 1 Gy 
Figure 2.  Artemis cells show proﬁ  cient checkpoint induction and a pro-
longed G2/M arrest. (A) PhosphoH3 analysis of primary human ﬁ  broblasts 
after 1.3 and 6 Gy x-irradiation. (B) PhosphoH3 analysis of MEFs after 
3 Gy γ-irradiation. Data shown are the percentage of mitotic cells relative 
to unirradiated cells at time 0. (C) FACS analysis of BrdU-labeled primary 
human ﬁ  broblasts. The percentage of BrdU-positive cells in late S/G2 was 
assessed up to 12 h after 1 Gy x-irradiation given at 4 h after BrdU label-
ing (i.e., when BrdU-labeled cells have progressed into late S/G2). Dotted 
lines represent the percentage of BrdU-positive cells in late S/G2 without 
irradiation. Error bars indicate SEM.JCB • VOLUME 176 • NUMBER 6 • 2007  752
and analyzed for chromosome breaks per mitotic cell at early 
times (2 and 4 h) after IR, similar to that undertaken in previ-
ous studies (Kemp and Jeggo, 1986). In all cell lines, chromo-
some breaks decreased with time refl  ecting DSB repair (Fig. 3, 
A and B). A-T cells show a pronounced elevation of the num-
ber of chromosome breaks per mitotic cell (approximately 
threefold higher than WT cells), whereas Artemis cells exhibit 
about twofold more breaks per cell than WT cells, consistent 
with Artemis’s repair function in G2 (Fig. 3 A). Thus, a com-
bined checkpoint and repair defect is more severe than a repair 
defect alone.
We also evaluated the contribution of repair and check-
point loss to chromosome aberration formation by using the 
checkpoint inhibitor SB218078. This drug has been described 
to impact upon Chk1 activity (Zhao et al., 2002) and abolishes 
53BP1 foci formation after hydroxyurea treatment, a Chk1-
  dependent phenotype (Fig. S3 A, available at http://www.jcb.org/
cgi/content/full/jcb.200612047/DC1; Sengupta et al., 2004). 
Addition of SB218078 completely abolished the G2/M check-
point response in primary human fi  broblasts as well as in MEFs 
(Fig. S3, B and C), whereas repair of IR-induced DSBs in G2 
remained unaffected (Fig. S3 D). SB218078 had no effect on 
chromosome aberration formation in A-T cells but increased the 
level of chromosome breaks per cell in Artemis cells to that of 
A-T cells (Fig. 3 B). WT cells treated with SB218078 showed 
considerably fewer breaks per cell than drug-treated A-T or Ar-
temis cells, which represents the contribution of ATM/Artemis-
dependent DSB repair to the prevention of chromosome 
aberrations in the absence of checkpoints. It is noteworthy that 
the cells forming chromosome aberrations are those in G2 at the 
time of irradiation, as the addition of aphidicolin prevented 
S phase cells from progressing into G2 during analysis. Thus, 
any role of Chk1 in replication fork stability will not affect 
chromosome aberration formation. Moreover, SB218078 did 
not cause chromosome breaks in the absence of IR.
Cells released from the G2/M checkpoint 
exhibit chromosome aberrations in mitosis
Our studies predict that 1 Gy–irradiated G2 phase Artemis cells 
would harbor 9–12 DSBs that remain unrepaired for prolonged 
times. The release of Artemis cells from G2/M checkpoint ar-
rest 6–8 h after irradiation suggested that the G2/M checkpoint 
might be unable to detect 9–12 DSBs. To investigate whether 
DSB repair is complete at the point of checkpoint release, we 
evaluated chromosome aberrations in mitotic cells that arise af-
ter checkpoint release (i.e., at time points >4 h after IR; Fig. 3). 
Because WT and Artemis cells progress from G2 into G1 within 
12 h after IR with 1 Gy (see Fig. 2 C), we evaluated chromo-
some breakage up to this time point. Strikingly, the level of 
chromosome aberrations in WT and Artemis cells at times when 
the cells that had initiated the checkpoint leave G2 (4–8 h in WT 
and 6–10 h in Artemis) is approximately one to two breaks per 
cell (Fig. 3 A), which is >10-fold above the background num-
ber of chromosome breaks. Thus, almost all cells released from 
the G2 checkpoint exhibit chromosome aberrations in mitosis. 
This observation represents direct experimental evidence that 
the human G2/M checkpoint is not maintained until the comple-
tion of repair.
This prompted us to investigate the time course for the ap-
pearance of chromosome aberrations in mitosis. Cells entering 
mitosis at early times exhibit more chromosome breaks than 
cells entering at later times (Fig. 3 A). However, this analysis 
fails to consider the number of cells reaching mitosis at each 
time point. Thus, we assessed the number of cells reaching mi-
tosis under the same conditions used for our chromosomal stud-
ies (i.e., in the presence of aphidicolin) by using phosphoH3 
FACS analysis (Fig. 3 C) and estimated the total number of 
  mitotic chromosome breaks by multiplying the chromosome 
breaks per cell by the number of mitotic cells (Fig. 3 D; see 
Materials and methods for details of this estimation). Considering 
this novel concept, we examined the kinetics for mitotic chro-
mosome breakage and observed a maximum at times after the 
G2/M checkpoint has been released (i.e., at 6–8 h in WT and at 
8–10 h in Artemis cells). Thus, cells released from the check-
point (at ≥6 h after IR) as opposed to cells that escape check-
point arrest at early times (at ≤4 h after IR) represent a major 
cause of mitotic chromosome breakage (Fig. 3 D). We also eval-
uated the number of cells reaching mitosis from the progression 
Figure 3.  ATM’s repair and checkpoint functions contribute to prevent 
chromosome breakage. (A) Chromosome breaks per mitotic cell in meta-
phase spreads from primary human ﬁ  broblasts harvested at varying times 
after 1 Gy x-irradiation in the presence of aphidicolin. Breaks in unirradi-
ated samples were <0.1 and were subtracted from the breaks in the irradi-
ated samples. (B) Same analysis as in A in the presence of the Chk1/2 
inhibitor SB218078. SB218078 did not cause chromosome breaks in un-
irradiated cells. (C) PhosphoH3 analysis of primary human ﬁ  broblasts 
  after 1 Gy x-irradiation in the presence of aphidicolin (i.e., the same 
  conditions used for the chromosomal analysis). The measured MIs were 
normalized to provide the same integral value of 1 for all three cell lines. 
(D) Estimation of the kinetics for total mitotic chromosome breakage. The 
values are derived from the number of chromosome breaks per mitotic cell 
for cells that enter mitosis at speciﬁ  c time points (taken from A) multiplied 
by the number of cells reaching mitosis at these times (taken from C). Error 
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of BrdU-labeled G2 cells (obtained from Fig. 2 C). An estima-
tion of the kinetics for mitotic chromosome breakage using this 
analysis provided similar results to that using the phosphoH3 
FACS data (Fig. S3 E). Thus, the concept of evaluating chromo-
some breakage by considering breaks per mitotic cell as well 
as the number of mitotic cells reveals the striking fi  nding that 
checkpoint release before the completion of repair represents 
a major cause for chromosome aberration formation. Remark-
ably, the total number of breaks in released cells is similar in 
WT and Artemis cells, although they arise with delayed kinetics 
in the repair-defective cells. The decrease in breaks at prolonged 
times after treatment (>10 h) is due to the depletion of irradi-
ated G2 cells; i.e., nearly all cells have left G2. A-T cells display 
entirely different kinetics. Because of the lack of checkpoint ar-
rest, they display an elevated number of chromosome breaks 
that decreases with time in part because of DSB repair and the 
rapid depletion of the G2 population.
The G2/M checkpoint has a deﬁ  ned threshold
Our fi  ndings establish that all cells released from the G2 check-
point harbor unrepaired damage, strongly suggesting that the 
G2/M checkpoint has a threshold. Our observation that Artemis 
cells remain checkpoint arrested longer than WT cells (Fig. 2) 
but are released with a similar number of γH2AX foci (Fig. 1 A) 
or mitotic chromosome breaks (Fig. 3 A) supports this notion. 
However, we sought other procedures to confi  rm the presence 
of DSBs in G2 at the time of checkpoint release and to evaluate 
the sensitivity limit of the G2 checkpoint. As one approach, we 
performed premature chromosome condensation (PCC) of G2 
cells using the phosphatase inhibitor calyculin A (Fig. 4 A). G2 
cells are readily distinguished from mitotic cells and allow the 
analysis of PCC breaks (Asakawa and Gotoh, 1997). At 4 and 6 h 
after 1 Gy x-irradiation, the time at which checkpoint release 
commences in WT and Artemis cells, respectively, we observed 
three to four PCC breaks per cell consolidating the presence of 
DSBs at the time of checkpoint release (Fig. 4 A). Moreover, 
WT cells at 4 h and Artemis cells at 6 h harbor a similar number 
of PCC breaks. Interestingly, these studies also provide an addi-
tional demonstration of a repair defect in Artemis cells. Previ-
ous studies equating PCC breaks with DSBs estimated by PFGE 
have reported a 1:3–6 relationship (i.e., 3–6 DSBs equate to 
1 PCC break; Cornforth and Bedford, 1993). Thus, our PCC 
data suggest a sensitivity level of 10–20 DSBs.
We also used γH2AX foci as a further marker to determine 
whether DSB repair is complete at the time of checkpoint re-
lease. We scored the number of foci in CENP-F–positive G2 
phase cells at differing times after IR and, in the same population 
of cells, counted the number of mitotic cells (Fig. 4 B). We used 
exponentially growing transformed human fi  broblasts, which 
provide a high mitotic index (MI). Mitotic cells were scored as 
phosphoH3-positive cells with condensed chromatin. Consistent 
with these fi  ndings, we observed that checkpoint duration in-
creases with dose and that cells are released from the checkpoint 
with  20 foci (Fig. 4 B). Similar results were obtained with 
hTert-immortalized fi  broblasts (unpublished data). We also ana-
lyzed mitotic cells at the 6-h time point and observed foci num-
bers similar to those of G2 cells, demonstrating that the cells 
released from the checkpoint do enter mitosis with foci and that 
there is no selection for cells exiting the checkpoint (Fig. S3 F; 
Rothkamm et al., 2003; Syljuasen et al., 2006). Previously, 
we and others have observed a 1:1 relationship between γH2AX 
foci and DSBs (Rogakou et al., 1999; Redon et al., 2002; 
Rothkamm and Löbrich, 2003). Although it is possible that 
γH2AX foci analysis could overestimate DSBs remaining if 
Figure 4.  The G2/M checkpoint has a thresh-
old of  3.5 PCC breaks and  20 𝗄H2AX foci. 
(A) Analysis of G2 PCC chromosomal breaks 
in calyculin A–treated cells in the presence 
of aphidicolin at 2, 4, and 6 h after 1 Gy 
x-  irradiation. Breaks in unirradiated samples 
were <0.2 and were subtracted from the breaks 
in the irradiated samples. P < 0.01 (t test) for 
AT1BR, AT7BI, CJ179, and F01-204 com-
pared with HSF1 or C2906 at 4 and 6 h (but not 
at 2 h). (B) γH2AX analysis and mitotic count-
ing of transformed MRC-5V1 ﬁ  broblasts  at 
varying times after 1, 2, and 10 Gy x-irradiation 
in the presence of aphidicolin. The analysis 
was done on the same samples by counting 
the fraction of phosphoH3-positive mitotic cells 
and foci numbers in CENP-F–positive G2 cells, 
respectively. The pronounced decline in MI at 
8 h after 1 and 2 Gy likely reﬂ  ects the deple-
tion of G2 cells. (C, left) Same analysis as in B 
evaluating transformed (MRC-5V1; gray bars, 
diamonds) and immortalized (48BR hTert; 
shaded bars, squares) ﬁ  broblasts 2 h after 0, 
0.2, 0.6, 1, and 2 Gy x-irradiation. (right) 
PhosphoH3 analysis of primary (48BR) 
  ﬁ  broblasts after 0, 0.1, 0.3, 0.5, and 1 Gy 
x-irradiation by FACS. γH2AX foci were scored 
on parallel samples and provided similar 
  numbers to those of MRC-5V1 and 48BR hTert cells. Analysis was performed 1 h after IR, as pilot experiments showed that primary cells show a more 
rapid onset of checkpoint arrest. Note that very short exposure times were required to deliver the low doses in these experiments, resulting in potential errors 
in the estimated dosimetry. Error bars indicate SEM.JCB • VOLUME 176 • NUMBER 6 • 2007  754
  repair is completed before the loss of visible foci, this is unlikely 
to occur in Artemis-defi  cient cells, where unrepaired DSBs per-
sist for many days in G1 and G2. Thus, our studies analyzing 
γH2AX foci are consistent with a threshold of 10–20 DSBs. 
  Additionally, our PFGE studies with G2 (Fig. 1 C), and previously 
with G0 cells, show that  15% of the induced DSBs remain un-
repaired in Artemis cells for many days. PFGE studies estimated 
30–40 DSBs induced per Gy in G1 (Cedervall et al., 1995; 
  Löbrich et al., 1995). Because G2 Artemis cells irradiated with 
1 Gy are completely released from G2 by 12 h, the estimated 
persisting damage level (15% of 60–80 DSBs induced: 9–12 
DSBs) is unable to maintain the checkpoint. In contrast, after 
6 Gy, the level of DSBs remaining exceeds the threshold and re-
sults in arrest being maintained for at least 16 h. Hence, our 
PFGE data, which do not rely on γH2AX foci analysis, also in-
dicate that the G2/M checkpoint threshold is >9–12 DSBs.
To evaluate whether induction of the G2/M checkpoint 
has a similar sensitivity limit, we analyzed transformed and im-
mortalized fi  broblasts exposed to doses up to 2 Gy at 2 h after 
irradiation, the earliest time point at which we observed com-
plete arrest in pilot experiments (Fig. 4 C). Cells irradiated with 
0.6 Gy or higher show complete checkpoint arrest. The foci 
level 2 h after 0.6 Gy is  20. Lower levels cause a partial arrest 
(Fig. 4 C). Because repair occurs during the 2-h incubation nec-
essary to measure checkpoint induction, our fi  ndings are consis-
tent with a level of  20 foci being required to activate checkpoint 
arrest. We also considered it important to examine primary hu-
man cells. The low MI of primary cells necessitated FACS anal-
ysis to estimate MI, precluding a parallel evaluation of γH2AX 
foci formation. Our fi  ndings were similar to those obtained us-
ing transformed/immortalized cells (Fig. 4 C). Importantly, use 
of a lower dose, inducing <10 γH2AX foci did not induce any 
detectable arrest. Based on 30–40 DSBs induced per Gy in G1, 
20 DSBs are induced after doses of 0.25–0.33 Gy in G2 cells. 
This correlates with the mild checkpoint induction observed 
here after 0.2–0.3 Gy and the absence of checkpoint arrest after 
0.1 Gy (Fig. 4 C). Thus, these fi  ndings are consistent with a 
similar threshold number of DSBs (10–20) both activating and 
maintaining checkpoint arrest. The existence of a threshold for 
G2/M checkpoint arrest provides a potential explanation for 
low-dose hypersensitivity, a phenomenon describing exquisite 
cellular sensitivity at low radiation doses (Marples et al., 2004). 
Indeed, a G2/M threshold of  20 DSBs would predict the re-
ported survival responses.
In conclusion, we have examined the effi  cacy of ATM’s 
repair and checkpoint functions in G2 and dissected the contri-
bution of these two ATM functions to the avoidance of chromo-
somal breakage. We demonstrate that (1) the kinetics of DSB 
repair in G2 is similar to that in G1 and that A-T and Artemis 
cells display an epistatic repair defect in G2 identical to that in 
G1; (2) Artemis cells are G2/M checkpoint profi  cient; (3) chromo-
some breaks occur 0–4 h after IR in a small fraction of cells 
that fail to arrest at the G2/M checkpoint; (4) the majority of 
cells arrest at the G2/M checkpoint but give rise to one to two 
chromosome breaks upon release. This represents a major 
cause of chromosome aberration formation; and (5) the G2/M 
checkpoint has a defi  ned threshold, which we estimate to be 
approximately three to four PCC breaks or  10–20 DSBs. 
This threshold allows for the generation of one to two chromo-
some breaks in mitosis.
Materials and methods
Cell culture, chemicals, and irradiation
Cells were grown as described previously (Riballo et al., 2004). 10, 15, 
or 20% FCS was used depending on the cell line. For the FAR assay, cells 
were labeled with 37 kBq/ml [methyl-
3H]thymidine (2.81 TBq/mmol; GE 
Healthcare) for 1 h (electrophoresis was performed according to Kühne 
et al. [2004]). Aphidicolin and nocodazole (Sigma-Aldrich) were added at 
3 μg/ml and 100 ng/ml, respectively. Inhibition of Chk1 activity was 
achieved by addition of 2.5 μM SB218078 (Calbiochem) 30 min before 
IR. ATMi (KU55933; provided by G. Smith, KuDos Pharmaceuticals Ltd, 
Cambridge, UK) was added at 10 μM 30 min before IR. X-irradiation was 
performed at 90 or 120 kV, γ-irradiation using a 
137Cs-source. Dosimetry 
was performed with ion chambers and considered the increase in dose for 
cells grown on glass coverslips relative to plastic surfaces.
Metaphase spreads and PCC
To collect metaphases, 100 ng/ml colcemid (Sigma-Aldrich) was added 
2 h before harvesting (1 h for the 2-h time point and 4 h for the 12-h time 
point). For PCC analysis, cells were treated with 50 ng/ml calyculin 
A (Calbiochem) for 30 min before harvesting. Chromatid breaks and ex-
cess fragments (counted as two chromatid breaks) were scored in 20–100 
chromosome spreads from at least three independent experiments per 
data point.
FACS
Cells pulse-labeled with 10 μM BrdU (Roche) for 1 h were analyzed ac-
cording to standard protocols. For phosphoH3 staining, cells were per-
meabilized with PBS/0.25% Triton X-100 (15 min on ice), incubated in 
100 μl α-phosphoH3 antibody (Ser10; 7.5 μg/ml PBS/1% BSA; Upstate 
Biotechnology) overnight, and treated with the Alexa Fluor 488–conjugated 
goat α-mouse (MoBiTec) or an FITC-conjugated swine α-rabbit antibody 
(DakoCytomation) in PBS/1% BSA for 1 h, followed by 50 μg/ml propid-
ium iodide containing 0.5 mg/ml RNase in PBS for 30 min at room tem-
perature. Analysis was performed on a FACScan or FACSCalibur using the 
CellQuest software (Becton Dickinson).
Immunoﬂ  uorescence
Cells grown on coverslips were ﬁ  xed in 100% methanol (−20°C) for 30 min, 
permeabilized in acetone (−20°C) for 1 min, and washed three times for 
10 min in PBS/1% FCS. Samples were incubated with primary antibodies 
(monoclonal or polyclonal α-γH2AX antibody [1:200; Upstate Biotechnol-
ogy], polyclonal α–CENP-F and α–cyclin A antibody [1:200; Santa 
Cruz Biotechnology, Inc.], or polyclonal α-phosphoH3 antibody [Ser10; 
1:200; Upstate Biotechnology]) in PBS/1% FCS for 1 h at room tempera-
ture, washed in PBS/1% FCS three times for 10 min, and incubated with 
Alexa Fluor 488–, Alexa Fluor 546–, or Alexa Fluor 594–conjugated sec-
ondary antibodies (1:500; MoBiTec) for 1 h at room temperature. Cells 
were washed in PBS four times for 10 min and mounted using Vectashield 
mounting medium containing 4,6 diamidino-2-phenylindole (Vector Labo-
ratories). In a single experiment, cell counting was performed until at least 
40 cells and 40 foci were registered per sample. Each data point repre-
sents two to three independent experiments. Error bars represent the SEM 
between the different experiments.
Estimation of the kinetics for total chromosome breakage
Fig. 3 D aims to compare the time course for total mitotic chromosome 
breakage for three different cell lines: A-T, Artemis, and WT. We have 
measured for all three lines the MI at deﬁ  ned times after irradiation by 
phosphoH3 FACS analysis under the same conditions used for the chromo-
somal analysis, i.e., in the presence of aphidicolin (Fig. 3 C). However, 
different cell lines can vary considerably in their fraction of G2 phase cells. 
Moreover, the majority but not all G2-irradiated cells leave G2 within 
12 h with slight differences between the three cell lines (Fig. 2 C). We have 
considered the ﬁ  rst variation (different G2 proportions) by normalizing the 
phosphoH3 data in Fig. 3 C such that the sum of the MIs measured up to 
12 h after irradiation is the same for all three cell lines and the second varia-
tion by multiplying these MIs with the measured proportion of G2-irradiated 
cells that leave G2 within 12 h. The latter values are derived from Fig. 2 C. CHROMOSOME BREAKAGE AFTER G2 CHECKPOINT RELEASE • DECKBAR ET AL. 755
For example, Artemis cells entering mitosis at 8 h after IR exhibit  1.5 
breaks per mitotic cell (Fig. 3 A). At this time, the relative MI for Artemis 
cells is  0.35. Thus, we multiplied the value of 1.5 by 1,000 (to normalize 
it to 1,000 irradiated G2 cells), by 0.75 (because 75% of all irradiated 
G2 Artemis cells leave G2 within 12 h; Fig. 2 C), and ﬁ  nally by 0.35 
  (because 35% of all cells that leave G2 within 12 h do this at the 8-h time 
point). This provides a value of  400 mitotic breaks for Artemis cells at 
8 h (Fig. 3 D).
Online supplemental material
Fig. S1 provides additional information for the experimental procedures used 
to measure DSB repair in G2 and shows that A-T and Artemis MEFs exhibit 
a DSB repair defect in G1 and G2. Fig. S2 provides additional information 
that Artemis cells show normal G2/M checkpoint induction and a prolonged 
arrest by counting mitotic cells and by using phosphoH3 FACS analysis. 
Fig. S3 shows that the Chk1-inhibiting drug SB218078 abolishes the G2/M 
checkpoint without affecting IR-induced DSB repair in G2 and provides evi-
dence that cells released from G2/M checkpoint arrest exhibit chromosome 
breaks and γH2AX foci in mitosis. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200612047/DC1.
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